TY - JOUR
T1 - Consensus-based recommendations for optical coherence tomography angiography reporting in uveitis
AU - Pichi, Francesco
AU - Salas, Ester Carreño
AU - Pavesio, Carlos
AU - Denniston, Alastair K.
AU - Grewal, Dilraj S.
AU - Deak, Gabor
AU - Khairallah, Moncef
AU - Ruiz-Cruz, Matilde
AU - De Oliveira Dias, Joao Rafael
AU - Adan, Alfredo
AU - Burke, Tomas
AU - Invernizzi, Alessandro
AU - Schlaen, Ariel
AU - Tian, Meng
AU - Agarwal, Aniruddha Kishandutt
AU - Tucker, William R.
AU - Sen, H. Nida
AU - Lin, Phoebe
AU - Lim, Lyndell L.
AU - Pepple, Kathryn L.
AU - Munk, Marion R.
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2022.No commercial re-use.See rights and permissions.Published by BMJ.
PY - 2022
Y1 - 2022
N2 - Background/aims: To establish a consensus in the nomenclature for reporting optical coherence tomography angiography (OCTA findings in uveitis.Methods: The modified Delphi process consisted of two rounds of electronic questionnaires, followed by a face-to-face meeting conducted virtually.Twenty-one items were included for discussion.The three main areas of discussion were: wide field OCTA (WF-OCTA), nomenclature of OCTA findings and OCTA signal attenuation assessment and measurement.Seventeen specialists in uveitis and retinal imaging were selected by the executive committee to constitute the OCTA nomenclature in Uveitis Delphi Study Group.The study endpoint was defined by the degree of consensus for each question: € strong consensus' was defined as >90% agreement, € consensus' as 85%-90% and € near consensus' as >80% but <85%.Results: There was a strong consensus to apply the term € wide field' to OCTA images measuring over 70° of field of view, to use the terms € flow void' and € non-detectable flow signal' to describe abnormal OCTA flow signal secondary to vessels displacement and slow flow respectively, to use the terms € loose' and € dense' to describe the appearance of inflammatory choroidal neovascularisation, and to use the percentage of flow signal decrease to measure OCTA ischaemia with a threshold greater than or equal to 30% as a € large area'.Conclusions: This study sets up consensus recommendations for reporting OCTA findings in uveitis by an expert panel, which may prove suitable for use in routine clinical care and clinical trials.
AB - Background/aims: To establish a consensus in the nomenclature for reporting optical coherence tomography angiography (OCTA findings in uveitis.Methods: The modified Delphi process consisted of two rounds of electronic questionnaires, followed by a face-to-face meeting conducted virtually.Twenty-one items were included for discussion.The three main areas of discussion were: wide field OCTA (WF-OCTA), nomenclature of OCTA findings and OCTA signal attenuation assessment and measurement.Seventeen specialists in uveitis and retinal imaging were selected by the executive committee to constitute the OCTA nomenclature in Uveitis Delphi Study Group.The study endpoint was defined by the degree of consensus for each question: € strong consensus' was defined as >90% agreement, € consensus' as 85%-90% and € near consensus' as >80% but <85%.Results: There was a strong consensus to apply the term € wide field' to OCTA images measuring over 70° of field of view, to use the terms € flow void' and € non-detectable flow signal' to describe abnormal OCTA flow signal secondary to vessels displacement and slow flow respectively, to use the terms € loose' and € dense' to describe the appearance of inflammatory choroidal neovascularisation, and to use the percentage of flow signal decrease to measure OCTA ischaemia with a threshold greater than or equal to 30% as a € large area'.Conclusions: This study sets up consensus recommendations for reporting OCTA findings in uveitis by an expert panel, which may prove suitable for use in routine clinical care and clinical trials.
KW - imaging
KW - inflammation
UR - http://www.scopus.com/inward/record.url?scp=85134464961&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85134464961&partnerID=8YFLogxK
U2 - 10.1136/bjophthalmol-2021-320021
DO - 10.1136/bjophthalmol-2021-320021
M3 - Article
C2 - 35135783
AN - SCOPUS:85134464961
SN - 0007-1161
JO - British Journal of Ophthalmology
JF - British Journal of Ophthalmology
M1 - 320021
ER -